View in EDS HTML Full Text PDF Full Text

Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.

Saved in:
Bibliographic Details
Title: Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
Authors: Jo H; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tatyoshi@ncc.go.jp.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan. tatyoshi@ncc.go.jp., Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan., Matsumoto Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Respiratory Endoscopy Division, Department of Endoscopy, National Cancer Center Hospital, Tokyo, Japan., Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Yamamoto N; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Takahashi K; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Feb; Vol. 71 (2), pp. 387-398. Date of Electronic Publication: 2021 Jun 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0851
DOI:10.1007/s00262-021-02997-2